Browse studies

Find your next paid study

3,234 recruiting studies matching your filters

A Prospective, Single-Center Study to Test the AdaptDx Pro Agreement in Rod Intercept Time With the AdaptDx in Healthy Subjects With Normal Vision (FlashBack)

The purpose of this study is to test the AdaptDx Pro agreement in Rod Intercept (RI) time with the AdaptDx tabletop (AdaptDx) in healthy subjects with normal v…

Healthy Adult Participants

Estimated

~$10 – $1,050

Actual pay is set by the research site.

AdaptDx, Inc.NCT07803588

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

The investigators' overall objective is to assess the incidence of critical events related to tracheal intubation at all international study sites. Furthermore…

Intubation ComplicationAdverse Events

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Thomas RivaNCT05804188

Phase 2

A Phase II Study of Acalabrutinib, Lenalidomide, and Rituximab (aR2) in Patients With Previously Untreated Follicular Lymphoma

This phase II trial studies how well acalabrutinib, lenalidomide, and rituximab work in treating patients with CD20 positive stage III-IV, grade 1-3a follicula…

Ann Arbor Stage III Grade 1 Follicular LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 3 Follicular Lymphoma+4 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer Center

Phase 1

GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy

This is a single-site, randomized, controlled treatment trial evaluating perioperative steroid hydrocortisone use in patients undergoing pancreatic resection (…

Pancreatic CancerPancreatic AdenocarcinomaDuodenal Cancer+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Illinois at ChicagoNCT07796997

Phase 3

RASolute 305: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (Modified FOLFIRINOX or Gemcitabine Plus Nab-Paclitaxel) With or Without Zoldonrasib (RMC-9805) as First-line Treatment in Patients With Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared to placebo…

Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Revolution Medicines, Inc.

Phase 1

A Phase I/II Trial of Cabozantinib in Combination With Durvalumab (MEDI4736) With or Without Tremelimumab in Patients With Advanced Gastroesophageal Cancer and Other Gastrointestinal (GI) Malignancies (CAMILLA)

The investigators propose to evaluate the safety of drug combinations in patients with advanced gastroesophageal cancer and other gastrointestinal (GI) maligna…

Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Anwaar SaeedNCT03539822

Phase 2

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

The goal of this study is to learn if individualized dosimetry-based prescribing of Lutetium-177 DOTATATE (Lutathera, Novartis Pharmaceuticals) improves treatm…

Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of IowaNCT06395402

Phase 1

Pilot Study: Evaluation of Novel Data-Driven Outcomes Via Response-Guided Systems Medicine in Hormone Receptor-Positive Advanced Breast Cancer (ENDORSE)

This clinical trial tests the feasibility and utility of a biology guided therapy recommendations report to aid in determining treatment of hormone receptor po…

Advanced Hormone Receptor-Positive Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+2 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

City of Hope Medical CenterNCT07590583

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

The current study will investigate if QbMobile can be used to improve the accuracy and objective identification of reduced ADHD symptoms in tests scores once t…

Attention Deficit Disorder With Hyperactivity (ADHD)Attention Deficit Disorder (ADD)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Qbtech ABNCT07217977

Phase 1

A Phase I Trial of Revumenib in Combination With 7+3 (7 Days of Cytarabine and 3 Days of Daunorubicin) + Midostaurin Induction Chemotherapy for the Frontline Treatment of NPM1 and FLT3 Mutated AML

This research is being conducted to determine a safe and effective dose of revumenib that can be given in combination with standard induction (initial therapy …

Acute Myeloid LeukemiaAML, AdultAML With Gene Mutations+2 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Richard Stone, MDNCT06313437

A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment

Many clinical trials evaluating cancer treatments require patients to undergo testing for specific molecular markers as part of eligibility screening, typicall…

Neoplasms (Cancer / Tumors)Colorectal NeoplasmsLung Neoplasms+8 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Harvard Medical School (HMS and HSDM)NCT07814872

Phase 3

Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer

This is a pragmatic, non-inferiority randomized hybrid decentralized clinical trial. The goal of this study is to determine if one year of maintenance immunoth…

Endometrial AdenocarcinomaMetastatic Endometrial CancerEndometrial Cancer+1 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT07867002